Medicare Enrolled

Dr. Anson Wurapa, M.D.

Infectious Disease · Decatur, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2665 N DECATUR RD, Decatur, GA 30033
4042979755
In practice since 2006 (20 years)
NPI: 1871531442 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wurapa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wurapa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wurapa

Dr. Anson Wurapa is an infectious disease specialist in Decatur, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wurapa performed 565 Medicare services across 296 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wurapa received a total of $37,867 from 44 pharmaceutical and/or device companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wurapa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 50% volume in GA $37,867 industry payments

Medicare Practice Summary

Medicare Utilization ↗
565
Medicare services
Top 50% in GA for infectious disease
296
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
206 $63 $190
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
76 $140 $490
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
71 $96 $279
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
70 $53 $253
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $90 $303
Wound tissue removal, 20 sq cm or less
This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less.
45 $29 $145
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
39 $169 $609
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$37,867
Total received (2018-2024)
Avg $5,410/year across 7 years
Top 8% in GA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
290
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,305 (53.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,477 (32.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,086 (13.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,345
2023
$1,265
2022
$5,527
2021
$808
2020
$3,919
2019
$1,146
2018
$4,858

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$10,124
ViiV Healthcare Company
$10,057
Aroa Biosurgery Incorporated
$66
ABBVIE INC.
$55
Smith+Nephew, Inc.
$24
Organogenesis Inc.
$18
Top 3 companies account for 99.5% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$23,335
Gilead Sciences, Inc.
$11,424
Merck Sharp & Dohme Corporation
$443
AbbVie Inc.
$215
Insmed, Inc.
$211
Janssen Scientific Affairs, LLC
$182
ABBVIE INC.
$181
Smith+Nephew, Inc.
$147
Melinta Therapeutics, Inc.
$129
Janssen Biotech, Inc.
$128
Merck Sharp & Dohme LLC
$128
Theravance Biopharma, Inc.
$127
TETRAPHASE PHARMACEUTICALS, INC.
$121
AbbVie, Inc.
$97
Allergan Inc.
$93
Organogenesis Inc.
$88
Aroa Biosurgery Incorporated
$80
Paratek Pharmaceuticals, Inc.
$63
Theratechnologies Inc.
$61
Kerecis Limited
$48
Astellas Pharma US Inc
$47
Mylan Institutional Inc.
$46
Shionogi Inc
$44
Vyera Pharmaceuticals, LLC
$41
Melinta Therapeutics, LLC
$34
Integra LifeSciences Corporation
$32
Takeda Pharmaceuticals U.S.A., Inc.
$28
Smith & Nephew, Inc.
$26
Mylan Specialty L.P.
$22
Next Science LLC
$21
Mylan Pharmaceuticals Inc.
$20
Nabriva Therapeutics, plc
$20
Cumberland Pharmaceuticals, Inc.
$18
Horizon Therapeutics plc
$18
VYERA PHARMACEUTICALS, LLC
$17
Octapharma USA, Inc.
$17
Grifols USA, LLC
$17
PFIZER INC.
$17
Allergan, Inc.
$15
EMD Serono, Inc.
$15
Ferring Pharmaceuticals Inc.
$15
GlaxoSmithKline, LLC.
$14
Dynavax Technologies Corporation
$14
Reprise Biomedical, Inc.
$8
Top 3 companies account for 93.0% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · APRETUDE · AVYCAZ · Arikayce · Baxdela · Biktarvy · CABENUVA · COLLAGENASE SANTYL · CRESEMBA · Cimduo · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim · Daraprim Tablet 25mg · EGRIFTA · Fetroja · GRAFIX · HYQVIA · Heplisav-B · ISENTRESS · Integra · JULUCA · Kerecis Omega3 SurgiClose · MAVYRET · MIRODERM · Mavyret · NOXAFIL · NUZYRA · PANZYGA · PIFELTRO · PREVNAR 20 · PREZCOBIX · PREZISTA · PROFORE · Puraply · REGRANEX · RUKOBIA · Rezzayo · SHINGRIX · SYMTUZA · Santyl · Serostim · SurgX · Symfi Lo · Symtuza · TIVICAY · TRIUMEQ · TROGARZO · VIBATIV · Vabomere · Vibativ · XERAVA · Xembify · Xenleta · Xerava · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for infectious disease in GA.

Looking for an infectious disease specialist in Decatur?
Compare infectious diseases in the Decatur area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
198
Per 100K population
26.0
County median income
$77,683
Nearest hospital
EMORY DECATUR HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wurapa is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wurapa experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Wurapa performed 206 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wurapa receive payments from pharmaceutical companies?
Yes. Dr. Wurapa received a total of $37,867 from 44 companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wurapa's costs compare to other infectious diseases in Decatur?
Dr. Wurapa's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wurapa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →